Plasma-lyte

Plasma-Lyte is a crystalloid solution for intravenous infusion, with varying electrolyte formulation depending on market. Generally the solution has a composition that mimics human physiological plasma electrolyte concentrations, osmolality and pH.[1]

Plasma-lyte 148 (pH7.4)

Plasma-Lyte 148 is a market-specific solution available in the United Kingdom and Australia, among others and has the following composition:

Sodium 140 mmol/l
Potassium 5 mmol/l
Magnesium 1.5 mmol/l
Chloride 98 mmol/l
Acetate 27 mmol/l
Gluconate 23 mmol/l

This solution is manufactured and marketed by Baxter International Inc.[2]

gollark: Rust.Rust.Rust.Rust.

gollark: Rust.

References

1: Rizoli S. PlasmaLyte. J Trauma. 2011 May;70(5 Suppl):S17-8. doi: 10.1097/TA.0b013e31821a4d89. PMID 21841561.
2: Baxter. Plasma-Lyte 148 product information. 2013. available at URL: http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/plasmalyte148_pi.pdf Archived 2017-06-23 at the Wayback Machine

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] 1: Rizoli S. PlasmaLyte. J Trauma. 2011 May;70(5 Suppl):S17-8. doi: 10.1097/TA.0b013e31821a4d89. PMID 21841561.

[2] 2: Baxter. Plasma-Lyte 148 product information. 2013. available at URL: http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/plasmalyte148_pi.pdf Archived 2017-06-23 at the Wayback Machine